Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>3-Hydroxyglutaric Acid

3-Hydroxyglutaric Acid (Synonyms: 2,4-Dideoxypentaric Acid, 3-HG, 3-Hydroxyglutarate, β-Hydroxyglutaric Acid, 3-Hydroxypentanedioic Acid, 3-OH-GA)

Catalog No.GC41477

Glutaryl-CoA dehydrogenase (GCDH) is a mitochondrial matrix protein that catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and carbon dioxide in the catabolic pathways of lysine, hydroxylysine, and tryptophan metabolism.

Products are for research use only. Not for human use. We do not sell to patients.

3-Hydroxyglutaric Acid Chemical Structure

Cas No.: 638-18-6

Size Price Stock Qty
1mg
$11.00
In stock
5mg
$50.00
In stock
10mg
$79.00
In stock
25mg
$149.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glutaryl-CoA dehydrogenase (GCDH) is a mitochondrial matrix protein that catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and carbon dioxide in the catabolic pathways of lysine, hydroxylysine, and tryptophan metabolism. 3-Hydroxyglutaric acid is one of several metabolites produced when insufficient levels of GCDH are available. Urinary levels of 3-hydroxyglutaric acid are elevated during glutaric acidemia type 1, an autosomal recessive GCDH deficiency disorder that can lead to neurodegeneration if left untreated. 3-Hydroxyglutaric acid is used as a biomarker of GCDH deficiency.

Reviews

Review for 3-Hydroxyglutaric Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 3-Hydroxyglutaric Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.